Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adrenomedullin in biologics-resistant Crohn's disease (phase 2a, randomized, double-blind, placebo-controlled)
jRCT2080223890Phase 2Completed
- Sponsor
- University of Miyazaki
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Crohn's disease comparing Adrenomedullin infusion with Placebo infusion (2 arms). Started May 2018; status: completed.
02
Drugs
fispemifene
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on jRCT2080223890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223890.